Depression

Lactofem Probiotic May Boost SSRI Efficacy & Counteract Sexual Side Effects in Women with Depression (2024 Trial)

by

Probiotics may help improve sexual function and reduce depression severity in women treated with SSRIs. Highlights: Depression Prevalence: Approximately 5% of all adults will experience depressive disorder, often accompanied by reduced sexual desire and dysfunction. Study Design: The study was a double-blind randomized clinical trial involving 112 women with depressive disorder treated with SSRIs, comparing …

Read more

Cancer-Related Suicide Trends in the U.S. (40-Year Analysis) (2024)

by

A comprehensive study of nearly 5 million cancer patients over 40 years revealed fluctuating trends in cancer-related suicides in the U.S., with a recent significant decrease likely due to advancements in psychosocial care and cancer treatment. Highlights: Data: Analyzed data from 4,870,410 cancer patients in the US between 1975 and 2017. Trend: Suicide rates increased …

Read more

Depression Linked to Topographic & Dynamic Reorganization of Global Brain Activity (2024)

by

Major depressive disorder (MDD) involves a topographic reorganization of brain activity from sensory to associative regions, affecting symptom co-occurrence through changes in neural dynamics and excitation-inhibition balance. Highlights: Topographic Reorganization: MDD patients show a shift in brain activity from unimodal sensory regions to transmodal associative regions. Neural Dynamics: This shift includes changes in the brain’s …

Read more

Antidepressant Mechanisms of Aerobic Exercise (2024 Review)

by

Aerobic exercise reduces depressive symptoms by decreasing inflammation, boosting dopamine transmission, and enhancing motivation and cognitive control. Highlights: Depression & Dopamine: Depression is linked to disrupted dopamine transmission, affecting reward processing and motivation, particularly in effort-based decision-making. Inflammation’s Role: Exercise reduces systemic inflammation, which otherwise impairs dopamine transmission and contributes to depressive symptoms like anhedonia …

Read more

Omega-3 Fatty Acids & Depression vs. Genetics: EPA-to-DHA Ratio (2024 Study)

by

Omega-3 fatty acids, particularly eicosapentaenoic acid (EPA), may reduce the risk of major depressive disorder (MDD), but causality remains uncertain due to potential pleiotropic mechanisms. Highlights: Genetic Evidence for Omega-3 & Depression: The study used two-sample Mendelian randomization to investigate the causality between genetically predicted omega-3 fatty acid levels and major depression, finding a protective …

Read more

Ketamine Alters Sleep Architecture in Depression: Delta Waves, Alpha Waves, Beta Waves (2024 Study)

by

A study examined the effects of ketamine on sleep arousal metrics in individuals with treatment-resistant depression (TRD) vs. healthy volunteers, finding that ketamine increases certain sleep-related brain activities but does not significantly mediate its antidepressant effects through these sleep changes. Highlights: Individuals with TRD had lower total sleep time and shorter REM latency compared to …

Read more

Case Report: Ozempic (Semaglutide) Worsening Depression in 54-Year-Old Female (2024)

by

GLP-1 receptor agonists like semaglutide, used for managing Type 2 diabetes, may be linked to adverse mood changes, necessitating further investigation into their psychiatric effects. Highlights: GLP-1 Receptor Agonists: These medications mimic GLP-1 hormone effects, enhancing insulin secretion and reducing appetite, commonly used for Type 2 diabetes management. Mood Effects: Data on the impact of …

Read more

How Common Are Antidepressant Withdrawal Symptoms? Estimated in 31% of Patients (2024 Review)

by

Antidepressant withdrawal symptoms occur in about one-third of patients stopping antidepressants, with severe symptoms in about 3% of cases – according to a new Lancet Psychiatry review. Highlights: Incidence of Symptoms: Approximately 31% of patients experience at least one discontinuation symptom after stopping antidepressants, compared to 17% for those stopping placebo. Severe Symptoms: Around 3% …

Read more

Lower Intracortical Myelination in Depression within Lateral Orbitofrontal Cortex (2024 Study)

by

A study used a 7-Tesla MRI to discover that major depressive disorder (MDD) is linked to lower intracortical myelination, particularly in brain regions associated with negative emotions. Highlights: Advanced MRI: The study used Ultra-High Field MRI at 7.0 Tesla to gain detailed insights into brain microstructures in MDD patients. Brain Regions: Researchers focused on the …

Read more

rTMS Improves Blood Biomarkers (BDNF, GDNF, Thiol, S100B) in Depression (2024 Study)

by

Repetitive transcranial magnetic stimulation (rTMS) therapy improves key biochemical markers in major depressive disorder (MDD) patients, indicating its effectiveness as an antidepressant treatment. Highlights: Improved Antioxidant Levels: rTMS therapy significantly increased total antioxidant status (TAS), total thiol (TT), and native thiol (NT) levels in MDD patients compared to their levels before treatment. Reduced Oxidative Stress: …

Read more

+ Load more